Circulating microRNAs as potential biomarkers for monitoring the response to in vivo treatment with Rituximab in systemic lupus erythematosus patients.

Authors	Irene Cecchi, Carlos Perez-Sanchez, Savino Sciascia, Massimo Radin, Ivan Arias de la Rosa, Nuria Barbarroja Puerto, Luca Scudeler, Laura Perez-Sanchez, Alejandra Maria Patiño Trives, Maria Angeles Aguirre Zamorano, Elisa Menegatti, Dario Roccatello, Chary Lopez-Pedrera
Journal	Autoimmunity reviews (Autoimmun Rev) Vol. 19 Issue 4 Pg. 102488 (Apr 2020) ISSN: 1873-0183 [Electronic] Netherlands
PMID	32062026 (Publication Type: Letter)
Chemical References	Biomarkers Circulating MicroRNA Rituximab
Topics	Adult Biomarkers (blood) Circulating MicroRNA (blood) Cohort Studies Female Humans Lupus Erythematosus, Systemic (blood, drug therapy) Male Rituximab (therapeutic use) Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!